ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 143 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $24,000 | +380.0% | 305,400 | +2626.8% | 0.00% | – |
| Q3 2018 | $5,000 | – | 11,200 | +6.7% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 10,500 | -93.5% | 0.00% | – |
| Q3 2015 | $1,000 | -83.3% | 160,500 | -8.2% | 0.00% | – |
| Q2 2015 | $6,000 | -90.0% | 174,900 | +16.6% | 0.00% | -100.0% |
| Q1 2015 | $60,000 | -99.5% | 150,000 | -93.2% | 0.00% | -99.0% |
| Q4 2014 | $11,138,000 | +70.2% | 2,221,242 | +31.1% | 0.41% | +59.7% |
| Q3 2014 | $6,544,000 | +60.5% | 1,694,357 | +6.5% | 0.26% | +70.9% |
| Q2 2014 | $4,078,000 | +306.6% | 1,590,288 | +16.7% | 0.15% | +235.6% |
| Q1 2014 | $1,003,000 | +0.3% | 1,362,773 | -3.6% | 0.04% | +40.6% |
| Q4 2013 | $1,000,000 | -26.0% | 1,414,006 | +215.8% | 0.03% | -25.6% |
| Q3 2013 | $1,352,000 | +102.1% | 447,733 | +447.7% | 0.04% | +87.0% |
| Q2 2013 | $669,000 | – | 81,751 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |